Featured Research

from universities, journals, and other organizations

Washington pediatricians receive regular requests for alternative child immunization schedules

Date:
November 28, 2011
Source:
Seattle Children's
Summary:
Seventy-seven percent of Washington state pediatricians report that they are sometimes or frequently asked to provide alternative childhood vaccine schedules for their patients, according to a new study.

Seventy-seven percent of Washington state pediatricians report that they are sometimes or frequently asked to provide alternative childhood vaccine schedules for their patients, according to a new study from Seattle Children's Research Institute. Researchers also found that 61 percent of Washington state pediatricians are comfortable using an alternative schedule when asked by a parent.

The study is published in the December 2011 issue of Pediatrics and is the first to evaluate pediatricians' attitudes towards alternative schedules.

"When discussing alternative childhood immunization schedules, pediatricians have to balance two things: respecting the parents' decision and protecting the health of the child," said Doug Opel, MD, MPH, bioethicist at Seattle Children's Research Institute and a University of Washington acting assistant professor of pediatrics. "This is a difficult and important discussion, and what we found was that most pediatricians are comfortable being flexible with the immunization schedule when parents ask for this flexibility."

The group of 209 pediatricians included in the study were least willing to revise the schedule for three vaccinations: diphtheria-tetanus toxoids-acellular pertussis vaccine (DTaP), Haemophilus influenzae type b vaccine (Hib) and pneumococcal conjugate vaccine (PCV). This suggests physicians want to prioritize immunizations that protect against some of the most common and most dangerous diseases which may occur during infancy and early childhood. Skipping the DTaP vaccine, for example, could lead to pertussis, also known as whooping cough. Pertussis is still common in the U.S. with frequent outbreaks. The Hib and PCV vaccines protect against infections like meningitis and pneumonia.

"The study demonstrates the need for more research on the use of alternative immunization schedules and the safety, efficacy and consequences of delaying immunizations," said Dr. Opel. Seattle Children's Research Institute will continue to study this topic to better understand the effect of childhood immunization schedules on individuals and public health.

Dr. Opel's co-authors were: Aaron Wightman, MD, Seattle Children's Research Institute and University of Washington; Edgar Marcuse, MD, MPH, Seattle Children's Research Institute and University of Washington and James Taylor, MD, University of Washington.


Story Source:

The above story is based on materials provided by Seattle Children's. Note: Materials may be edited for content and length.


Journal Reference:

  1. Aaron Wightman, Douglas J. Opel, Edgar K. Marcuse, James A. Taylor. Washington State Pediatricians' Attitudes Toward Alternative Childhood Immunization Schedules. Pediatrics, 2011; DOI: 10.1542/peds.2011-0666

Cite This Page:

Seattle Children's. "Washington pediatricians receive regular requests for alternative child immunization schedules." ScienceDaily. ScienceDaily, 28 November 2011. <www.sciencedaily.com/releases/2011/11/111128152420.htm>.
Seattle Children's. (2011, November 28). Washington pediatricians receive regular requests for alternative child immunization schedules. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2011/11/111128152420.htm
Seattle Children's. "Washington pediatricians receive regular requests for alternative child immunization schedules." ScienceDaily. www.sciencedaily.com/releases/2011/11/111128152420.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins